Evidence map›Paper›PMID 20378534›Full record

ArticleThe Journal of biological chemistry2010

Structure and mechanism of sanguinarine reductase, an enzyme of alkaloid detoxification.

Matthias Vogel, Michael Lawson, Wolfgang Sippl, Udo Conrad, Werner Roos

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. California poppy (Frontiers in plant science · 2023
    Review
  4. Journal of advanced research · 2021
    Article
  5. Enhancement of Macarpine Production inMolecules (Basel, Switzerland) · 2020
    Article
  6. Review
  7. Toxicological Effects of Berberine and Sanguinarine.Frontiers in molecular biosciences · 2018
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Matthias VogelDepartment of Pharmaceutical Biology, Laboratory of Molecular Cell Biology, the Martin-Luther-University of Halle-Wittenberg, 06120 Halle, Saale, Germany.
Michael Lawson
Wolfgang Sippl
Udo Conrad
Werner Roos
Martin Luther University Halle-Wittenberg · DEInstitute of Molecular and Cell Biology · RULeibniz Institute of Plant Genetics and Crop Plant Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sanguinarine reductase is a plant enzyme that prevents the cytotoxic effects of benzophenanthridine alkaloids, which are the main phytoalexins of Papaveraceae. The enzyme catalyzes the reduction of sanguinarine, the most toxic benzophenanthridine, which re-enters the cytoplasm after its primary accumulation in the cell wall region has reached a threshold concentration. We present the sequence of the gene and protein of sanguinarine reductase isolated from cell cultures of Eschscholzia californica. High sequence similarities indicate that the enzyme evolved from a plant-specific branch of the ubiquitous Rossmann fold NAD(P)H/NAD(P)(+) binding reductases, with NADP-dependent epimerases or hydroxysteroid reductases as the most likely ancestors. Based on the x-ray structure of a close homolog, a three-dimensional model of the spatial conformation and catalytic site of sanguinarine reductase was established and used for in silico screening of known three-dimensional structures. Surprisingly, the enzyme shares high structural similarity with enzymes of human and bacterial origin, which have similar functions as the plant homologs but bear little amino acid sequence similarity. Using site-directed mutagenesis, a series of recombinant enzymes was generated and assayed to reveal the impact of individual amino acids and peptides in the catalytic process. It appears that relatively few innovations were required to generate this selective catalyst for alkaloid detoxication, notably an insertion of 13 amino acids and the generation of a novel catalytic triad of Cys-Asp-His were sufficient.

Indexed as

Amino AcidsAmino Acid SequenceBenzophenanthridinesBiochemistryCatalysisCytoplasmEschscholziaIsoquinolinesMolecular Sequence DataMutagenesis, Site-DirectedNADPOxidoreductasesOxidoreductases Acting on CH-NH Group DonorsPeptidesPlant ProteinsPlantsAmino AcidsBenzophenanthridinesIsoquinolinesNADPOxidoreductasesOxidoreductases Acting on CH-NH Group DonorsPeptidesPlant ProteinsRecombinant Proteinssanguinarinesanguinarine reductase, Eschscholzia californica

Identifiers

PMID20378534
PMCPMC2881765
OpenAlexW1607580885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.